Long-term clinical course of patients with pleuroparenchymal fibroelastosis treated with noninvasive positive pressure ventilation - 17/06/22
Doi : 10.1016/j.resmer.2022.100906
Satoshi Hamada a, ⁎ 
, Tomohiro Handa a, Satona Tanaka b, Hiroshi Date b, Toyohiro Hirai c
, Tomohiro Handa a, Satona Tanaka b, Hiroshi Date b, Toyohiro Hirai c a Department of Advanced Medicine for Respiratory Failure, Graduate School of Medicine, Kyoto University, Kyoto, Japan
b Department of Thoracic Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan
c Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan
⁎Corresponding author at: Department of Advanced Medicine for Respiratory Failure, Graduate School of Medicine, Kyoto University, 54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan.Department of Advanced Medicine for Respiratory FailureGraduate School of Medicine, Kyoto University54 Shogoin Kawahara-cho, Sakyo-kuKyoto606-8507Japan
Key words : Hypercapnia, Noninvasive positive pressure ventilation, Pleuroparenchymal fibroelastosis, Pneumothorax
Le texte complet de cet article est disponible en PDF.
Plan
© 2022
SPLF and Elsevier Masson SAS. Tous droits réservés.
Vol 81
Article 100906- mai 2022 Retour au numéro
Article précédent
- “Early” and “delayed” intubation of COVID-19 patients: Different definitions, different populations
- Samuel Chosidow, Damien Contou, Megan Fraissé, Olivier Pajot, Hervé Mentec, Radj Cally, Gaëtan Plantefève
- Screening for latent polycythemia vera in chronic obstructive pulmonary disease-associated erythrocytosis
- Stephen E. Langabeer
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?